ArticleBMJ global health2018

Forecasted impacts of a sofosbuvir-based national hepatitis C treatment programme on Egypt's hepatocellular cancer epidemic: simulation of alternatives.

Wenkang Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.